βοΈ
Medical Disclaimer
The information on this page is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.
Always seek the advice of your doctor or other qualified health professional with any questions you may have regarding a medical condition.
π¨Emergency? If you have severe symptoms, difficulty breathing, or think it's an emergency, call 000 immediately.
Avascular Necrosis of the Humeral Head
Comprehensive guide to causes, staging, and treatment of humeral head AVN including core decompression, biological treatments, and joint replacement surgery decision-making
π
Last reviewed: December 2025π₯Bones & Joints
πWhat is Avascular Necrosis of the Humeral Head?
Comprehensive guide to causes, staging, and treatment of humeral head AVN including core decompression, biological treatments, and joint replacement surgery decision-making
π¬What Causes It?
- Post-traumatic (most common shoulder AVN cause) - proximal humerus fracture 15-30% develop AVN, especially 3-4 part fractures
- Chronic glucocorticoid use (prednisone >20mg daily for >3 months) - second most common cause, 5-10% develop AVN
- Excessive alcohol consumption (>3 drinks/day long-term) - disrupts lipid metabolism, fat emboli block blood vessels
- Sickle cell disease - sickled cells occlude small vessels in humeral head
- Idiopathic (no identifiable cause) - 20-30% of cases, often bilateral
β οΈRisk Factors
βΉοΈ
You may be at higher risk if:
- Proximal humerus fracture (especially 3-4 part fractures with disrupted blood supply)
- Chronic prednisone therapy >20mg daily (lupus, rheumatoid arthritis, transplant patients)
- Heavy alcohol use (>3 standard drinks daily long-term)
- Sickle cell disease or trait
- Previous shoulder dislocation (especially if multiple dislocations or delayed reduction >12 hours)
- Diving or decompression sickness (caisson disease - nitrogen bubbles)
- Chemotherapy or radiation therapy to shoulder region
π‘οΈPrevention
- βMinimize glucocorticoid exposure - use lowest effective dose, shortest duration, steroid-sparing agents when possible
- βAlcohol moderation or abstinence - heavy use (>3 drinks/day) doubles AVN risk
- βPrompt anatomic reduction of proximal humerus fractures - delays >24 hours increase AVN risk
- βSickle cell disease optimization - hydroxyurea therapy, avoid dehydration/cold exposure (sickling triggers)
- βBilateral screening - if AVN diagnosed one shoulder, MRI opposite shoulder (40-60% bilateral involvement within 2-5 years)
- βSerial MRI monitoring if high-risk (prednisone >20mg daily, alcohol use, sickle cell) - early detection allows joint-preserving surgery